Regenovue Fine Plus

Regenovue presents a series of cross-linked hyaluronic-acid-based fillers from the South Korean company NeoGenesis Co., Ltd. Regenovue products have an exceptional HA cross-linking rate (100%) and one of the lowest BDDE levels in the market of dermal fillersRegenovue is a dermal hyaluronic acid- (HA)-based filler with the 100% cross-linked structure. Innovative patented technology of HA cross-linking is used in the production of Regenovue. The product has outstanding purity, which means a minimum concentration of BDDE-derived by-products. Regenovue fillers are characterized by high elasticity and viscosity thus providing their even distribution and a long-lasting esthetic effect. Compact structure of the gel guarantees a constant injection pressure (uniform injection rate), which makes the procedure as comfortable and easy as possible both for the patient and the specialist. Strengths of Regenovue: one of the lowest levels of residual BDDE among dermal fillers (<0.0015 IU/mg) long-lasting esthetic effect due to the high viscosity and elasticity of the filler painless and injury-free injection due to the finely-divided gel structure and the presence of lidocaine in the composition dense monophasic structure of the gel ensures its uniform distribution in the subcutaneous layers natural-looking effect the products contain HA of non-animal origin provides elasticity and moisture to the skin Regenovue Fine Plus is aimed at diminishing superficial wrinkles and fine lines. The filler is injected into the upper layers of the dermis. Scope of Regenovue Fine Plus: periorbital wrinkles (crow’s feet) glabellar lines perioral lines neck lines forehead lines The aesthetic effect lasts from 8 to 12 month. Product composition: HA 24 mg/ml, Lidocaine 0.3% Regenovue Fine Plus 1 syringe × 1.1 ml, 2 needles per pack Needle size: 30G
Less